Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IO Biotech, Inc. | 41,533 | reported | 08 Jun 2023 | tx 5+3,080,963−188,168 |
| ALX ONCOLOGY HOLDINGS INC | 20,200 | reported | 20 Jun 2023 | tx 4+68,217 |
| Crinetics Pharmaceuticals, Inc. | 12,500 | reported | 21 Jun 2019 | tx 1+12,500 |
| Harmony Biosciences Holdings, Inc. | 6,336 | reported | 29 May 2024 | tx 79+75,262−1,771,944 |
| Aligos Therapeutics, Inc. | 4,411 | reported | 28 Feb 2024 | tx 5+54,411−15,000 |
| Instil Bio, Inc. | 1,500 | reported | 14 Jun 2023 | tx 8+12,570,287−10,155,656 |
| REATA PHARMACEUTICALS INC | 1,201 | reported | 10 Jun 2021 | tx 13+55,849 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2024 | GRANT_AWARD | Harmony Biosciences Holdings, Inc. | 6,336 | 0.00 USD | deriv |
| 28 Feb 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 4,411 | 0.00 USD | deriv |
| 27 Feb 2024 | OTHER | Aligos Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Instil Bio, Inc. | 1,500 | 0.00 USD | deriv |
| 20 Jul 2023 | GRANT_AWARD | Aligos Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 20,200 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | IO Biotech, Inc. | 41,533 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | Harmony Biosciences Holdings, Inc. | 5,224 | 0.00 USD | deriv |
| 14 Dec 2022 | SALE | Harmony Biosciences Holdings, Inc. | 2,834 | 59.96 USD | |
| 07 Dec 2022 | SALE | Harmony Biosciences Holdings, Inc. | 64,026 | 60.35 USD | |
| 09 Dec 2022 | SALE | Harmony Biosciences Holdings, Inc. | 9,847 | 59.89 USD | |
| 08 Dec 2022 | SALE | Harmony Biosciences Holdings, Inc. | 36,878 | 59.90 USD | |
| 30 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 42,667 | 58.93 USD | |
| 01 Dec 2022 | SALE | Harmony Biosciences Holdings, Inc. | 65,652 | 60.00 USD | |
| 29 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 21,333 | 57.82 USD | |
| 21 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 24,898 | 57.08 USD | |
| 18 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 20,800 | 57.00 USD | |
| 22 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 31,902 | 57.60 USD | |
| 11 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 36,800 | 57.14 USD | |
| 15 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 62,933 | 56.80 USD | |
| 14 Nov 2022 | SALE | Harmony Biosciences Holdings, Inc. | 58,667 | 58.70 USD | |
| 08 Aug 2022 | SALE | Harmony Biosciences Holdings, Inc. | 75,000 | 53.56 USD | |
| 04 Aug 2022 | SALE | Harmony Biosciences Holdings, Inc. | 60,000 | 52.30 USD | |
| 05 Aug 2022 | SALE | Harmony Biosciences Holdings, Inc. | 115,000 | 52.42 USD | |
| 02 Aug 2022 | SALE | Harmony Biosciences Holdings, Inc. | 75,117 | 55.22 USD |
1 purchase reported after at least 12 months of silence — most recent on 20 Aug 2020.